ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
stockNASDAQ
Market OpenNov 3, 2026 3:26:21 PM EST
12.93USD+0.701%(+0.09)21,231
ELOX Financials
In Q2 FY 2026 (ended ), Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) reported net income of −$4.5M, operating cash flow of −$4.79M, and assets of $63.39M.
Loading financial statements…